BioMarin Pharmaceutical Ownership & Insider Activity

BioMarin Pharmaceutical Inc

BMRNNASDAQ

$67.68

-1.65-2.38%

가까이에: Aug 20, 5:00 PM EST

$67.68

N/A

시간외: 4:35 PM EST

인수합병: Alesta Therapeutics announced it will be acquired by BioMarin Pharmaceutical (BMRN) on Tuesday, August 18, 2026 for $275M

BioMarin Pharmaceutical (BMRN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.5% of shares outstanding. Institutional investors hold 69.2%.

Shares Outstanding

193.270M

Shares Float

192.758M

Insider Shares Owned

2.895M

Insider % Owned

1.5%

Institutional Shares Held

133.887M

Institutional % Held

69.2%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
May 7, 2026	Gregory Friberg	EVP, CHIEF R&D OFFICER	SELL	3.281K	$53.85	$177K
Mar 11, 2026	Greg Charles Guyer	EVP, CHIEF TECHNICAL OFFICER	SELL	16.486K	$60.46	$997K
Feb 26, 2026	Gregory Friberg	EVP, CHIEF R&D OFFICER	SELL	6.326K	$60.38	$382K
Feb 25, 2026	Eric George Davis	EVP, CHIEF LEGAL OFFICER	SELL	10.837K	$61.36	$1.6M

Date	Member	Party	Chamber	Action	Amount
Mar 6, 2023	Daniel Goldman	D	House	S	$1,001 - $15,000